Literature DB >> 19334328

Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.

Joan M Irizarry-Alvarado1, Jamie P Dwyer, Lisa M Brumble, Salvador Alvarez, Julio C Mendez.   

Abstract

We report 3 cases of patients with HIV/AIDS in whom Fanconi syndrome and nephrogenic diabetes insipidus developed secondary to use of an antiretroviral regimen containing tenofovir disoproxil fumarate and didanosine. These patients presented with a history of polydipsia, polyuria, weight loss, anorexia, and wasting. Interestingly, 1 patient was not taking protease inhibitors. This response is a well-documented yet uncommon complication of tenofovir use in the HIV population. We recommend continued monitoring for renal toxicity when using NRTI combination of tenofovir and didanosine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19334328

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  14 in total

1.  Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.

Authors:  Trevor Hawkins; Wenoah Veikley; Lucie Durand-Gasselin; Darius Babusis; Y Sunila Reddy; John F Flaherty; Adrian S Ray
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 3.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 4.  Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Authors:  Jérôme Tourret; Gilbert Deray; Corinne Isnard-Bagnis
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

5.  Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens.

Authors:  Weerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Wisit Prasithsirikul; Preecha Tantanathip; Busakorn Suntisuklappon; Anongnuch Narkksoksung; Samruay Nilkamhang; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2010-10-11       Impact factor: 2.250

6.  Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort.

Authors:  Arlene C Chua; Ryan M Llorin; Kelvin Lai; Philippe Cavailler; Hwa Lin Law
Journal:  AIDS Res Ther       Date:  2012-06-15       Impact factor: 2.250

Review 7.  Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies.

Authors:  Syed K Haque; Gema Ariceta; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2012-12       Impact factor: 5.992

8.  Tenofovir nephrotoxicity: 2011 update.

Authors:  Beatriz Fernandez-Fernandez; Ana Montoya-Ferrer; Ana B Sanz; Maria D Sanchez-Niño; Maria C Izquierdo; Jonay Poveda; Valeria Sainz-Prestel; Natalia Ortiz-Martin; Alejandro Parra-Rodriguez; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  AIDS Res Treat       Date:  2011-06-07

9.  Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India.

Authors:  Ketan K Patel; Atul K Patel; Rajiv R Ranjan; Apurva R Patel; Jagdish K Patel
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-01

10.  New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.

Authors:  Nimish Patel; Christopher D Miller
Journal:  HIV AIDS (Auckl)       Date:  2012-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.